juvenile diabetes research foundation limited Company Information
Company Number
02071638
Next Accounts
Mar 2026
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
17/18 angel gate, city road, london, EC1V 2PT
Website
http://jdrf.org.ukjuvenile diabetes research foundation limited Estimated Valuation
Pomanda estimates the enterprise value of JUVENILE DIABETES RESEARCH FOUNDATION LIMITED at £4.1m based on a Turnover of £6.7m and 0.61x industry multiple (adjusted for size and gross margin).
juvenile diabetes research foundation limited Estimated Valuation
Pomanda estimates the enterprise value of JUVENILE DIABETES RESEARCH FOUNDATION LIMITED at £0 based on an EBITDA of £-373.1k and a 4.5x industry multiple (adjusted for size and gross margin).
juvenile diabetes research foundation limited Estimated Valuation
Pomanda estimates the enterprise value of JUVENILE DIABETES RESEARCH FOUNDATION LIMITED at £5.6m based on Net Assets of £2.3m and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Juvenile Diabetes Research Foundation Limited Overview
Juvenile Diabetes Research Foundation Limited is a live company located in london, EC1V 2PT with a Companies House number of 02071638. It operates in the other human health activities sector, SIC Code 86900. Founded in November 1986, it's largest shareholder is unknown. Juvenile Diabetes Research Foundation Limited is a mature, mid sized company, Pomanda has estimated its turnover at £6.7m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Juvenile Diabetes Research Foundation Limited Health Check
Pomanda's financial health check has awarded Juvenile Diabetes Research Foundation Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
3 Weak
Size
annual sales of £6.7m, make it larger than the average company (£720.7k)
£6.7m - Juvenile Diabetes Research Foundation Limited
£720.7k - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (8%)
2% - Juvenile Diabetes Research Foundation Limited
8% - Industry AVG
Production
with a gross margin of 38.6%, this company has a comparable cost of product (38.6%)
38.6% - Juvenile Diabetes Research Foundation Limited
38.6% - Industry AVG
Profitability
an operating margin of -6.3% make it less profitable than the average company (5.3%)
-6.3% - Juvenile Diabetes Research Foundation Limited
5.3% - Industry AVG
Employees
with 62 employees, this is above the industry average (18)
62 - Juvenile Diabetes Research Foundation Limited
18 - Industry AVG
Pay Structure
on an average salary of £49.4k, the company has a higher pay structure (£27.6k)
£49.4k - Juvenile Diabetes Research Foundation Limited
£27.6k - Industry AVG
Efficiency
resulting in sales per employee of £107.6k, this is more efficient (£49k)
£107.6k - Juvenile Diabetes Research Foundation Limited
£49k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (20 days)
0 days - Juvenile Diabetes Research Foundation Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 15 days, this is close to average (16 days)
15 days - Juvenile Diabetes Research Foundation Limited
16 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Juvenile Diabetes Research Foundation Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 203 weeks, this is more cash available to meet short term requirements (111 weeks)
203 weeks - Juvenile Diabetes Research Foundation Limited
111 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 20.3%, this is a lower level of debt than the average (24.8%)
20.3% - Juvenile Diabetes Research Foundation Limited
24.8% - Industry AVG
JUVENILE DIABETES RESEARCH FOUNDATION LIMITED financials
Juvenile Diabetes Research Foundation Limited's latest turnover from June 2024 is £6.7 million and the company has net assets of £2.3 million. According to their latest financial statements, Juvenile Diabetes Research Foundation Limited has 62 employees and maintains cash reserves of £2.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6,670,927 | 6,115,258 | 5,908,519 | 6,375,646 | 6,044,754 | 5,897,943 | 6,024,524 | 6,084,517 | 6,100,673 | 5,182,425 | 4,712,975 | 4,172,403 | 4,205,979 | 4,476,172 | 3,445,230 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pre-Tax Profit | -293,815 | -48,055 | 394,182 | 843,502 | 145,262 | -197,539 | -214,322 | 114,368 | 294,181 | 100,029 | 14,187 | -241,980 | -292,339 | 510,839 | -16,048 |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -293,815 | -48,055 | 394,182 | 843,502 | 145,262 | -197,539 | -214,322 | 114,368 | 294,181 | 100,029 | 14,187 | -241,980 | -292,339 | 510,839 | -16,048 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -293,815 | -48,055 | 394,182 | 843,502 | 145,262 | -197,539 | -214,322 | 114,368 | 294,181 | 100,029 | 14,187 | -241,980 | -292,339 | 510,839 | -16,048 |
Employee Costs | 3,063,919 | 2,600,058 | 2,369,018 | 2,287,961 | 2,421,635 | 2,490,307 | 2,484,542 | 2,390,532 | 2,201,736 | 1,883,490 | 1,822,576 | 1,767,992 | 1,527,091 | 1,427,034 | 1,258,018 |
Number Of Employees | 62 | 52 | 52 | 52 | 60 | 60 | 61 | 63 | 58 | 49 | 48 | 48 | 43 | 41 | 37 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 17,286 | 46,076 | 81,066 | 97,078 | 115,890 | 67,322 | 79,439 | 97,597 | 107,101 | 119,170 | 11,762 | 32,088 | 40,915 | 47,086 | 50,135 |
Intangible Assets | 51,585 | 65,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 68,871 | 111,576 | 81,066 | 97,078 | 115,890 | 67,322 | 79,439 | 97,597 | 107,101 | 119,170 | 11,762 | 32,088 | 40,915 | 47,086 | 50,135 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 16,907 | 54,490 | 614,644 | 72,394 | 101,180 | 34,610 | 158,620 | 359,889 | 533,725 | 343,382 | 55,243 | 457,571 | 384,696 | 113,052 | 540,041 |
Group Debtors | 0 | 235 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 505,856 | 327,062 | 0 | 351,253 | 309,370 | 563,121 | 265,120 | 228,488 | 212,382 | 195,636 | 511,307 | 156,644 | 112,489 | 797,107 | 84,547 |
Cash | 2,263,022 | 2,572,091 | 2,476,438 | 2,140,797 | 1,164,023 | 1,436,547 | 1,236,225 | 1,297,398 | 985,726 | 889,306 | 823,160 | 340,750 | 300,484 | 470,892 | 701,187 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 370,168 | 737,399 | 500,000 | 0 |
total current assets | 2,785,785 | 2,953,878 | 3,091,082 | 2,564,444 | 1,574,573 | 2,034,278 | 1,659,965 | 1,885,775 | 1,731,833 | 1,428,324 | 1,389,710 | 1,325,133 | 1,535,068 | 1,881,051 | 1,325,775 |
total assets | 2,854,656 | 3,065,454 | 3,172,148 | 2,661,522 | 1,690,463 | 2,101,600 | 1,739,404 | 1,983,372 | 1,838,934 | 1,547,494 | 1,401,472 | 1,357,221 | 1,575,983 | 1,928,137 | 1,375,910 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 176,891 | 58,567 | 51,749 | 55,010 | 5,555 | 35,108 | 35,991 | 59,100 | 46,026 | 60,085 | 81,396 | 53,351 | 23,492 | 99,748 | 89,134 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 3,788 | 9,138 | 14,487 | 19,836 | 25,185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 397,685 | 427,642 | 487,750 | 362,696 | 279,245 | 831,276 | 270,658 | 277,195 | 260,199 | 248,881 | 140,568 | 138,549 | 145,190 | 128,749 | 97,975 |
total current liabilities | 578,364 | 495,347 | 553,986 | 437,542 | 309,985 | 866,384 | 306,649 | 336,295 | 306,225 | 308,966 | 221,964 | 191,900 | 168,682 | 228,497 | 187,109 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 578,364 | 495,347 | 553,986 | 437,542 | 309,985 | 866,384 | 306,649 | 336,295 | 306,225 | 308,966 | 221,964 | 191,900 | 168,682 | 228,497 | 187,109 |
net assets | 2,276,292 | 2,570,107 | 2,618,162 | 2,223,980 | 1,380,478 | 1,235,216 | 1,432,755 | 1,647,077 | 1,532,709 | 1,238,528 | 1,179,508 | 1,165,321 | 1,407,301 | 1,699,640 | 1,188,801 |
total shareholders funds | 2,276,292 | 2,570,107 | 2,618,162 | 2,223,980 | 1,380,478 | 1,235,216 | 1,432,755 | 1,647,077 | 1,532,709 | 1,238,528 | 1,179,508 | 1,165,321 | 1,407,301 | 1,699,640 | 1,188,801 |
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 33,705 | 34,990 | 33,711 | 31,599 | 31,612 | 20,998 | 22,473 | 27,176 | 24,369 | 21,908 | 25,736 | 32,976 | 28,874 | 28,136 | 23,266 |
Amortisation | 13,915 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 140,976 | -232,857 | 190,997 | 13,097 | -187,181 | 173,991 | -164,637 | -157,730 | 207,089 | -27,532 | -47,665 | 117,030 | -412,974 | 285,571 | 624,588 |
Creditors | 118,324 | 6,818 | -3,261 | 49,455 | -29,553 | -883 | -23,109 | 13,074 | -14,059 | -21,311 | 28,045 | 29,859 | -76,256 | 10,614 | 89,134 |
Accruals and Deferred Income | -29,957 | -60,108 | 125,054 | 83,451 | -552,031 | 560,618 | -6,537 | 16,996 | 11,318 | 108,313 | 2,019 | -6,641 | 16,441 | 30,774 | 97,975 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | 0 | 0 | 0 | 0 | 0 | 0 | -4,315 | -17,672 | -12,300 | -129,317 | |||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | 0 | 0 | 0 | 0 | 0 | 0 | -4,315 | -17,672 | -12,300 | -129,317 | |||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | -5,350 | -5,349 | -5,349 | -5,349 | 25,185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from financing | -5,350 | -5,349 | -5,349 | -5,349 | 25,185 | 0 | 0 | 0 | 0 | -41,009 | 0 | 0 | 0 | 0 | 1,204,849 |
cash and cash equivalents | |||||||||||||||
cash | -309,069 | 95,653 | 335,641 | 976,774 | -272,524 | 200,322 | -61,173 | 311,672 | 96,420 | 66,146 | 482,410 | 40,266 | -170,408 | -230,295 | 701,187 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -309,069 | 95,653 | 335,641 | 976,774 | -272,524 | 200,322 | -61,173 | 311,672 | 96,420 | 66,146 | 482,410 | 40,266 | -170,408 | -230,295 | 701,187 |
juvenile diabetes research foundation limited Credit Report and Business Information
Juvenile Diabetes Research Foundation Limited Competitor Analysis
Perform a competitor analysis for juvenile diabetes research foundation limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in EC1V area or any other competitors across 12 key performance metrics.
juvenile diabetes research foundation limited Ownership
JUVENILE DIABETES RESEARCH FOUNDATION LIMITED group structure
Juvenile Diabetes Research Foundation Limited has 1 subsidiary company.
Ultimate parent company
JUVENILE DIABETES RESEARCH FOUNDATION LIMITED
02071638
1 subsidiary
juvenile diabetes research foundation limited directors
Juvenile Diabetes Research Foundation Limited currently has 7 directors. The longest serving directors include Mr Phillip Aird-Mash (Mar 2019) and Mr Barrie Brien (Mar 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Phillip Aird-Mash | 49 years | Mar 2019 | - | Director | |
Mr Barrie Brien | 58 years | Mar 2019 | - | Director | |
Mr Jared Chebib | 54 years | Dec 2020 | - | Director | |
Mr Wilson Leech | England | 63 years | Dec 2020 | - | Director |
Dr Per Lundin | 41 years | Mar 2021 | - | Director | |
Mrs Nadia Swann | 55 years | Mar 2023 | - | Director | |
Ms Sarah Johnson | 47 years | Mar 2023 | - | Director |
P&L
June 2024turnover
6.7m
+9%
operating profit
-420.7k
0%
gross margin
38.6%
-0.43%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
2.3m
-0.11%
total assets
2.9m
-0.07%
cash
2.3m
-0.12%
net assets
Total assets minus all liabilities
juvenile diabetes research foundation limited company details
company number
02071638
Type
Private Ltd By Guarantee w/o Share Cap
industry
86900 - Other human health activities
incorporation date
November 1986
age
39
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
June 2024
previous names
juvenile diabetes foundation (uk) limited(the) (March 2001)
accountant
-
auditor
BUZZACOTT LLP
address
17/18 angel gate, city road, london, EC1V 2PT
Bank
BARCLAYS BANK PLC
Legal Advisor
-
juvenile diabetes research foundation limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to juvenile diabetes research foundation limited.
juvenile diabetes research foundation limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for JUVENILE DIABETES RESEARCH FOUNDATION LIMITED. This can take several minutes, an email will notify you when this has completed.
juvenile diabetes research foundation limited Companies House Filings - See Documents
date | description | view/download |
---|